The combination of Vland’s core production technology and Evonik’s strong global market presence – as well as the shared focus on technology and application of probiotic solutions – is expected to bring mutual benefits to both partners, including new product developments.
“The JDA is expected to stimulate innovation and joint R&D activities in the field of selection, production, formulation and application of our new probiotic solution,” says Dr. Emmanuel Auer, head of Evonik’s Animal Nutrition Business Line.
“Evonik is excited to partner with Vland in this joint initiative to develop the next probiotic solution focusing on a more sustainable, efficient and environmentally-friendly production,” he added.
“Based on years’ cooperation, Vland and Evonik extend the scope to plant, livestock and aquaculture in the solution of probiotics products. After IPO, Vland focus on R&D and globalization, and strive to become a technology-driven enterprise,” says Aron Chen, CEO of Vland.